EICHOR
● Active Not Recruiting
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Condition: Anal Melanoma · Bladder Melanoma · Cervical Melanoma · Sponsor: National Cancer Institute (NCI)
About this study
This phase II trial tests whether nivolumab in combination with cabozantinib works in patients with mucosal melanoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It works by blocking the action of an abnormal protein that signals tumor cells to multiply. This helps stop the spread of tumor cells. Giving nivolumab in combination with cabozantinib could prevent cancer from returning.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (146)
| Sutter Auburn Faith Hospital | Auburn, California, United States | — |
| Alta Bates Summit Medical Center-Herrick Campus | Berkeley, California, United States | — |
| Palo Alto Medical Foundation-Fremont | Fremont, California, United States | — |
| Keck Medicine of USC Koreatown | Los Angeles, California, United States | — |
| Los Angeles General Medical Center | Los Angeles, California, United States | — |
| USC / Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| Memorial Medical Center | Modesto, California, United States | — |
| USC Norris Oncology/Hematology-Newport Beach | Newport Beach, California, United States | — |
| Palo Alto Medical Foundation Health Care | Palo Alto, California, United States | — |
| Stanford Cancer Institute Palo Alto | Palo Alto, California, United States | — |
| Sutter Roseville Medical Center | Roseville, California, United States | — |
| Sutter Medical Center Sacramento | Sacramento, California, United States | — |
+ 134 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05111574